scholarly article | Q13442814 |
meta-analysis | Q815382 |
P50 | author | Obi Griffith | Q30503239 |
P2093 | author name string | Simon K Chan | |
Steven J M Jones | |||
Isabella T Tai | |||
P433 | issue | 3 | |
P921 | main subject | colorectal cancer | Q188874 |
colorectal carcinoma | Q25493920 | ||
meta-analysis | Q815382 | ||
biomarker | Q864574 | ||
P304 | page(s) | 543-552 | |
P577 | publication date | 2008-03-01 | |
P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
P1476 | title | Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers | |
P478 | volume | 17 |
Q37141208 | A gene browser of colorectal cancer with literature evidence and pre-computed regulatory information to identify key tumor suppressors and oncogenes |
Q40883454 | A hypothesis-directed approach to the targeted development of a multiplexed proteomic biomarker assay for cancer |
Q37662920 | A proteomics approach to identifying novel protein targets involved in erinacine A-mediated inhibition of colorectal cancer cells' aggressiveness. |
Q28647460 | A reproducible approach to high-throughput biological data acquisition and integration |
Q35000434 | A systematic review of microRNA expression profiling studies in human gastric cancer. |
Q35116107 | Anti-cancer role of SPARC, an inhibitor of adipogenesis |
Q36254183 | Bioactive food components, inflammatory targets, and cancer prevention |
Q28469491 | CIL-102-Induced Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells via Upregulation of p21 and GADD45 |
Q58048546 | CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer |
Q50171133 | Candidate miRNAs in human breast cancer biomarkers: a systematic review |
Q37889251 | Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation |
Q37152727 | Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation |
Q34989110 | Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study. |
Q34249344 | Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance |
Q38910482 | Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation |
Q40887366 | Causal Genetic Inference Using Haplotypes as Instrumental Variables |
Q62583147 | Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations. |
Q36792372 | Clinical applications of gene expression in colorectal cancer |
Q43940466 | Clinical significance of SPARC gene expression in patients with gastric cancer |
Q54090244 | Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1. |
Q36545805 | Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation |
Q28647615 | Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach |
Q28396656 | Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas |
Q35769403 | Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies |
Q33889157 | Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies |
Q64111250 | Design, synthesis, and pharmacology of some oxadiazole and hydroxypyrazoline hybrids bearing thiazoyl scaffold: antiproliferative activity, molecular docking and DNA binding studies |
Q28732708 | Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing |
Q24600829 | Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma |
Q91981880 | Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer |
Q36537783 | Exact statistical tests for the intersection of independent lists of genes |
Q39214951 | Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions. |
Q36130607 | Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin |
Q34366990 | Gene expression profile of peripheral blood in colorectal cancer. |
Q33747019 | Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta-analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees. |
Q90087579 | Genome-wide bioinformatics analysis reveals CTCFL is upregulated in high-grade epithelial ovarian cancer |
Q84582220 | Genomic profiling of colorectal cancer |
Q36413124 | Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. |
Q64108433 | High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma |
Q33657299 | High-dimensional variable selection in meta-analysis for censored data |
Q21260380 | Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states |
Q57175678 | Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies |
Q38468383 | Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis |
Q38171299 | Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis |
Q49587340 | Identification of common key genes in breast, lung and prostate cancer and exploration of their heterogeneous expression |
Q44743866 | Identification of core miRNA based on small RNA-seq and RNA-seq for colorectal cancer by bioinformatics |
Q35087649 | Immunohistochemistry for myc predicts survival in colorectal cancer |
Q90283520 | Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells |
Q39068085 | Imputation of Truncated p-Values For Meta-Analysis Methods and Its Genomic Application |
Q37728657 | Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer |
Q92361660 | Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer |
Q33538043 | Integrative meta-analysis of differential gene expression in acute myeloid leukemia |
Q53638858 | Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression. |
Q37709450 | KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies |
Q33494759 | Measuring the combinatorial expression of solute transporters and metalloproteinases transcripts in colorectal cancer |
Q36276060 | Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia |
Q36411401 | Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues |
Q40156495 | Meta-analysis of kindling-induced gene expression changes in the rat hippocampus |
Q50983395 | Meta-analysis of microRNA expression profiling studies in human cervical cancer. |
Q55365878 | MicroRNA meta-signature of oral cancer: evidence from a meta-analysis. |
Q38004774 | MicroRNAs: relevant tools for a colorectal surgeon? |
Q56527730 | Microarray analysis of microRNA expression in liver cancer tissues and normal control |
Q38199932 | Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. |
Q38438819 | Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression |
Q39174595 | Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescence |
Q28749098 | Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data |
Q37649691 | Risk analysis of colorectal cancer incidence by gene expression analysis |
Q31083068 | SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer |
Q38018848 | Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies |
Q38108253 | Stromal expression of SPARC in pancreatic adenocarcinoma |
Q34772247 | Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development |
Q34439076 | Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis |
Q45894388 | Transcriptome analysis of human colorectal cancer biopsies reveals extensive expression correlations among genes related to cell proliferation, lipid metabolism, immune response and collagen catabolism |
Q40540347 | Unstable genomes elevate transcriptome dynamics |
Q92839882 | Urinary microRNAs as potential biomarkers for differentiating the "atypical urothelial cells" category of the Paris system for reporting urine cytology |
Q55031300 | Use of Jianpi Jiedu Herbs in Patients with Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis. |
Q34696767 | Verification of gene expression profiles for colorectal cancer using 12 internet public microarray datasets |
Q36544789 | miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers |